Lupin Somerset Morphine Sulfate Tablets Recall: Impurity Risk
Lupin Somerset recalls 30mg Morphine Sulfate Extended-Release Tablets (100-count) due to impurity issues found during stability testing. Affected lots may pose health risks.
Recall notice
Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
Contact the company
What happened, in plain English
Lupin Somerset is recalling Morphine Sulfate Extended-Release Tablets (30mg, 100-count) because testing found impurities that could be harmful. This recall affects prescription-only medication that may pose health risks if used without proper quality control. Read more at govinfonow.com/recall/39686-lupin-somerset-morphine-sulfate-tablets-recall-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39686-lupin-somerset-morphine-sulfate-tablets-recall-impurity-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1214-2018
Cite this page
“Lupin Somerset Morphine Sulfate Tablets Recall: Impurity Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39686-lupin-somerset-morphine-sulfate-tablets-recall-impurity-risk. Based on FDA recall #D-1214-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1214-2018%22&limit=1).
Why it’s dangerous
The recall is based on testing that found impurities in the Morphine Sulfate Extended-Release Tablets. These impurities could potentially cause health issues if the medication is used without proper quality control.
Who’s affected
Prescription patients who have the specific lot number (S800232) of Morphine Sulfate Extended-Release Tablets from Lupin Somerset. Those with the medication are most at risk due to potential impurities.
How to tell if you have this one
Check for the product name 'Morphine Sulfate Extended-Release Tablets', 30mg, 100-count bottle, prescription-only. Look for the lot number S800232 and expiration date 2/20 on the packaging.
- Brand
Lupin Somerset- Category
Drug
What to do — step by step
Check Product Details
Identify the lot number (S800232) and expiration date (2/20) on the packaging to confirm if the product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4.1 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class III
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1214-2018 (August 23, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1214-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.